- CA$22.38m
- CA$18.03m
- CA$19.96m
- 53
- 75
- 53
- 63
2019 March 31st | R2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 32.1 | 49.8 | 91.7 | 18.2 | 20 |
Cost of Revenue | |||||
Gross Profit | 9.57 | 11.7 | 20.8 | 7.85 | 8.12 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Operating Interest Expense / Income | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 35.4 | 55.4 | 91.5 | 24.2 | 23.3 |
Operating Profit | -3.35 | -5.53 | 0.263 | -6.08 | -3.38 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -3.16 | -3.81 | -3.27 | -5.88 | -3.26 |
Provision for Income Taxes | |||||
Net Income After Taxes | -2.12 | -2.62 | -3.17 | -5.94 | -3.86 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -2.23 | -2.65 | -2.9 | -4.39 | 0.032 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -2.23 | -2.65 | -2.9 | -4.39 | 0.032 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.083 | -0.057 | -0.134 | -0.141 | -0.083 |